ELV
Elevance Health Inc.$365.63+9.50 (+2.67%)Prev Close$356.13·MCap$70.48B·P/E1.51·Vol565.2K·Yield0.02%
▲
Buys (12M)
3
$3.68M
▼
Sells (12M)
5
$2.05M
◆
Net Activity
Net Buyer
$1.64M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Elevance Health Inc. (ELV) has been mixed between buying and selling, with 3 insider purchases totaling $3.68M and 5 insider sales totaling $2.05M. The most recent insider transaction was by SCHULMAN AMY W (director), who sold $7.5K worth of shares on Mar 23, 2026. Elevance Health Inc. operates in the Healthcare sector, within the Medical - Healthcare Plans industry, with a market cap of $70.48B.
ELV Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | SCHULMAN AMY W | director | Sell | 26 | $287.50 | $7.5K | 218 |
| Mar 9, 2026 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | Sell | 3,196 | $284.92 | $910.6K | 11,791 |
| Mar 6, 2026 | COLLIS STEVEN H | director | Buy | 3,000 | $289.84 | $869.5K | 3,639+469% |
| Feb 3, 2026 | Craig Ryan R | EVP & Chief HR Officer | Sell | 279 | $341.83 | $95.4K | 0 |
| Oct 3, 2025 | Kaye Mark | EVP & CFO | Sell | 2,895 | $340.24 | $985.0K | 0 |
| Sep 5, 2025 | Wessling Erin M | EVP & Chief Legal Officer | Sell | 152 | $321.59 | $48.9K | 0 |
| Aug 21, 2025 | DeVore Susan D. | Director | Buy | 1,200 | $312.15 | $374.6K | 0 |
| Jul 18, 2025 | BOUDREAUX GAIL | President and CEO | Buy | 8,500 | $286.94 | $2.44M | 0 |
| Apr 25, 2025 | Kaye Mark | EVP & CFO | Sell | 4,588 | $424.82 | $1.95M | 0 |
| Mar 11, 2025 | Penczek Ronald W | CAO & Controller | Sell | 443 | $415.13 | $183.9K | 0 |
| Mar 5, 2025 | BOUDREAUX GAIL | President and CEO | Sell | 10,396 | $395.50 | $4.11M | 0 |
| Mar 5, 2025 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 2,281 | $395.50 | $902.1K | 0 |
| Mar 5, 2025 | Kaye Mark | EVP & CFO | Sell | 270 | $395.50 | $106.8K | 0 |
| Mar 5, 2025 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 5,725 | $395.99 | $2.27M | 0 |
| Mar 5, 2025 | LAVU RATNAKAR | EVP, Chief Digital & Info Off | Sell | 312 | $395.50 | $123.4K | 0 |
| Mar 5, 2025 | Norwood Felicia F | EVP & President,Gov Health Ben | Sell | 2,613 | $395.50 | $1.03M | 0 |
| Mar 5, 2025 | Penczek Ronald W | CAO & Controller | Sell | 198 | $395.50 | $78.3K | 0 |
| Nov 1, 2024 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 1,649 | $414.01 | $682.7K | 17,238 |
| Nov 1, 2024 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 846 | $414.01 | $350.3K | 7,577 |
| Oct 18, 2024 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 7,417 | $432.14 | $3.21M | 8,423-47% |
| Oct 2, 2024 | Kaye Mark | EVP & CFO | Sell | 2,818 | $505.16 | $1.42M | 20,213 |
| Aug 5, 2024 | PERU RAMIRO G | Director | Sell | 753 | $531.52 | $400.2K | 8,744 |
| Jul 22, 2024 | BOUDREAUX GAIL | President and CEO | Sell | 34,000 | $500.98 | $17.03M | 159,609 |
| Jul 19, 2024 | Dixon Robert L JR | Director | Sell | 305 | $506.76 | $154.6K | 9,721 |
| Apr 23, 2024 | Norwood Felicia F | EVP & President,Gov Health Ben | Sell | 20,310 | $533.34 | $10.83M | 31,560-39% |
| Mar 8, 2024 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 2,432 | $500.46 | $1.22M | 15,840 |
| Mar 6, 2024 | Penczek Ronald W | CAO & Controller | Sell | 916 | $504.58 | $462.2K | 1,764-34% |
| Mar 1, 2024 | BOUDREAUX GAIL | President and CEO | Sell | 19,256 | $499.11 | $9.61M | 117,777 |
| Mar 1, 2024 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 25,409 | $500.00 | $12.70M | 35,776-42% |
| Mar 1, 2024 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 1,484 | $499.11 | $740.7K | 13,764 |
| Mar 1, 2024 | Norwood Felicia F | EVP & President,Gov Health Ben | Sell | 4,902 | $499.11 | $2.45M | 28,541 |
| Mar 1, 2024 | Penczek Ronald W | CAO & Controller | Sell | 383 | $499.11 | $191.2K | 1,408 |
| Mar 1, 2024 | Todt Blair Williams | EVP, CLO & CAO | Sell | 3,650 | $499.11 | $1.82M | 8,465-30% |
| Feb 7, 2024 | PERU RAMIRO G | Director | Sell | 753 | $500.00 | $376.5K | 9,109 |
| Jan 3, 2024 | Todt Blair Williams | EVP, CLO & CAO | Sell | 397 | $480.49 | $190.8K | 12,115 |
| Dec 14, 2023 | Todt Blair Williams | EVP, CLO & CAO | Sell | 5,492 | $484.02 | $2.66M | 12,512-31% |
| Dec 1, 2023 | Todt Blair Williams | EVP, CLO & CAO | Sell | 1,641 | $456.06 | $748.4K | 16,029 |
| Nov 30, 2023 | Penczek Ronald W | CAO & Controller | Sell | 1,055 | $475.17 | $501.3K | 1,787-37% |
| Nov 1, 2023 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 154 | $446.66 | $68.8K | 17,739 |
| Nov 1, 2023 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 79 | $446.66 | $35.3K | 15,248 |
| Oct 24, 2023 | Penczek Ronald W | CAO & Controller | Sell | 64 | $454.35 | $29.1K | 2,842 |
| Jul 21, 2023 | Dixon Robert L JR | Director | Sell | 310 | $476.71 | $147.8K | 9,638 |
| Mar 24, 2023 | MCCARTHY GLORIA M | EVP & Chief Administrative Off | Sell | 15,098 | $444.76 | $6.71M | 65,933 |
| Mar 9, 2023 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 2,314 | $462.22 | $1.07M | 15,327 |
| Mar 1, 2023 | BOUDREAUX GAIL | President and CEO | Sell | 20,085 | $468.81 | $9.42M | 135,863 |
| Mar 1, 2023 | Gallina John E | EVP & Chief Financial Officer | Sell | 5,237 | $468.81 | $2.46M | 63,725 |
| Mar 1, 2023 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 6,076 | $468.80 | $2.85M | 17,893-25% |
| Mar 1, 2023 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 1,377 | $468.83 | $645.6K | 17,641 |
| Mar 1, 2023 | MCCARTHY GLORIA M | EVP & Chief Administrative Off | Sell | 6,047 | $468.81 | $2.83M | 66,533 |
| Mar 1, 2023 | Norwood Felicia F | EVP & President, GBD | Sell | 5,249 | $468.80 | $2.46M | 33,443 |
Showing 1–50 of 93
1 / 2
ELV Insider Buying Activity
The following table shows recent insider purchases of Elevance Health Inc. (ELV) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | COLLIS STEVEN H | director | Buy | 3,000 | $289.84 | $869.5K | 3,639+469% |
| Aug 21, 2025 | DeVore Susan D. | Director | Buy | 1,200 | $312.15 | $374.6K | 0 |
| Jul 18, 2025 | BOUDREAUX GAIL | President and CEO | Buy | 8,500 | $286.94 | $2.44M | 0 |
ELV Insider Selling Activity
The following table shows recent insider sales of Elevance Health Inc. (ELV) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | SCHULMAN AMY W | director | Sell | 26 | $287.50 | $7.5K | 218 |
| Mar 9, 2026 | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | Sell | 3,196 | $284.92 | $910.6K | 11,791 |
| Feb 3, 2026 | Craig Ryan R | EVP & Chief HR Officer | Sell | 279 | $341.83 | $95.4K | 0 |
| Oct 3, 2025 | Kaye Mark | EVP & CFO | Sell | 2,895 | $340.24 | $985.0K | 0 |
| Sep 5, 2025 | Wessling Erin M | EVP & Chief Legal Officer | Sell | 152 | $321.59 | $48.9K | 0 |
| Apr 25, 2025 | Kaye Mark | EVP & CFO | Sell | 4,588 | $424.82 | $1.95M | 0 |
| Mar 11, 2025 | Penczek Ronald W | CAO & Controller | Sell | 443 | $415.13 | $183.9K | 0 |
| Mar 5, 2025 | BOUDREAUX GAIL | President and CEO | Sell | 10,396 | $395.50 | $4.11M | 0 |
| Mar 5, 2025 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 2,281 | $395.50 | $902.1K | 0 |
| Mar 5, 2025 | Kaye Mark | EVP & CFO | Sell | 270 | $395.50 | $106.8K | 0 |
| Mar 5, 2025 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 5,725 | $395.99 | $2.27M | 0 |
| Mar 5, 2025 | LAVU RATNAKAR | EVP, Chief Digital & Info Off | Sell | 312 | $395.50 | $123.4K | 0 |
| Mar 5, 2025 | Norwood Felicia F | EVP & President,Gov Health Ben | Sell | 2,613 | $395.50 | $1.03M | 0 |
| Mar 5, 2025 | Penczek Ronald W | CAO & Controller | Sell | 198 | $395.50 | $78.3K | 0 |
| Nov 1, 2024 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 1,649 | $414.01 | $682.7K | 17,238 |
| Nov 1, 2024 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 846 | $414.01 | $350.3K | 7,577 |
| Oct 18, 2024 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 7,417 | $432.14 | $3.21M | 8,423-47% |
| Oct 2, 2024 | Kaye Mark | EVP & CFO | Sell | 2,818 | $505.16 | $1.42M | 20,213 |
| Aug 5, 2024 | PERU RAMIRO G | Director | Sell | 753 | $531.52 | $400.2K | 8,744 |
| Jul 22, 2024 | BOUDREAUX GAIL | President and CEO | Sell | 34,000 | $500.98 | $17.03M | 159,609 |
| Jul 19, 2024 | Dixon Robert L JR | Director | Sell | 305 | $506.76 | $154.6K | 9,721 |
| Apr 23, 2024 | Norwood Felicia F | EVP & President,Gov Health Ben | Sell | 20,310 | $533.34 | $10.83M | 31,560-39% |
| Mar 8, 2024 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 2,432 | $500.46 | $1.22M | 15,840 |
| Mar 6, 2024 | Penczek Ronald W | CAO & Controller | Sell | 916 | $504.58 | $462.2K | 1,764-34% |
| Mar 1, 2024 | BOUDREAUX GAIL | President and CEO | Sell | 19,256 | $499.11 | $9.61M | 117,777 |
| Mar 1, 2024 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 25,409 | $500.00 | $12.70M | 35,776-42% |
| Mar 1, 2024 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 1,484 | $499.11 | $740.7K | 13,764 |
| Mar 1, 2024 | Norwood Felicia F | EVP & President,Gov Health Ben | Sell | 4,902 | $499.11 | $2.45M | 28,541 |
| Mar 1, 2024 | Penczek Ronald W | CAO & Controller | Sell | 383 | $499.11 | $191.2K | 1,408 |
| Mar 1, 2024 | Todt Blair Williams | EVP, CLO & CAO | Sell | 3,650 | $499.11 | $1.82M | 8,465-30% |
| Feb 7, 2024 | PERU RAMIRO G | Director | Sell | 753 | $500.00 | $376.5K | 9,109 |
| Jan 3, 2024 | Todt Blair Williams | EVP, CLO & CAO | Sell | 397 | $480.49 | $190.8K | 12,115 |
| Dec 14, 2023 | Todt Blair Williams | EVP, CLO & CAO | Sell | 5,492 | $484.02 | $2.66M | 12,512-31% |
| Dec 1, 2023 | Todt Blair Williams | EVP, CLO & CAO | Sell | 1,641 | $456.06 | $748.4K | 16,029 |
| Nov 30, 2023 | Penczek Ronald W | CAO & Controller | Sell | 1,055 | $475.17 | $501.3K | 1,787-37% |
| Nov 1, 2023 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 154 | $446.66 | $68.8K | 17,739 |
| Nov 1, 2023 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 79 | $446.66 | $35.3K | 15,248 |
| Oct 24, 2023 | Penczek Ronald W | CAO & Controller | Sell | 64 | $454.35 | $29.1K | 2,842 |
| Jul 21, 2023 | Dixon Robert L JR | Director | Sell | 310 | $476.71 | $147.8K | 9,638 |
| Mar 24, 2023 | MCCARTHY GLORIA M | EVP & Chief Administrative Off | Sell | 15,098 | $444.76 | $6.71M | 65,933 |
| Mar 9, 2023 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 2,314 | $462.22 | $1.07M | 15,327 |
| Mar 1, 2023 | BOUDREAUX GAIL | President and CEO | Sell | 20,085 | $468.81 | $9.42M | 135,863 |
| Mar 1, 2023 | Gallina John E | EVP & Chief Financial Officer | Sell | 5,237 | $468.81 | $2.46M | 63,725 |
| Mar 1, 2023 | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 6,076 | $468.80 | $2.85M | 17,893-25% |
| Mar 1, 2023 | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 1,377 | $468.83 | $645.6K | 17,641 |
| Mar 1, 2023 | MCCARTHY GLORIA M | EVP & Chief Administrative Off | Sell | 6,047 | $468.81 | $2.83M | 66,533 |
| Mar 1, 2023 | Norwood Felicia F | EVP & President, GBD | Sell | 5,249 | $468.80 | $2.46M | 33,443 |
ELV Insiders
Kendrick Charles Morgan JR
officer: EVP & President, Commercial
Sold $13.99M
12 tradesLast: Mar 9, 2026